Susan Hasty, Publisher
Table of Contents . . . February 1st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Agilent Technologies, Inc. - Chip maker acquires gene regulation analysis company
American Medical Systems Holdings, Inc. - Medicare payment value corrected for Her Option cryoablation therapy
Correctional Health - Jury awards $1.2 million to two men sickened in jail infection
Genaissance Pharmaceuticals, Inc. - Patent granted for methods to correlate genetics with drug safety and efficacy
Information Technology - DecisionPath inks contract with U.S. Social Security Administration
Insmed Incorporated - Biopharmaceutical company comments on recent actions by Tercica, Inc.
Legal Issues - Wyoming advocacy group sues state over treatment of mentally ill patients
NMT Medical, Inc. - Patient enrollment for migraine intervention initiated
OccuLogix, Inc. - Pharma company enrolls patients in age-related macular degeneration trial
Oscient Pharmaceuticals Corporation - Pharma company announces new hires
Personnel - Former FDA staffers Dan Troy and Coleen Klasmeier join law firm
SCOLR Pharma, Inc. - Pharma company names new hire to newly created positions
Vasomedical, Inc. - Medicare payment for EECP therapy for cardiovascular disease increases
Winstead Sechrest & Minick P.C - Texas law firm launches biotechnology practice, hires 4 pharma legal experts
ARUP Inst. for Clinical & Experimental Pathology - Microsphere-based immunoassay suitable for detection of ENA autoantibodies
Acambis plc - Fast track status granted for ACAM2000 smallpox vaccine
Adolor Corporation - U.S. FDA seeks more data on phase III trial of alvimopan in postoperative ileus
Aerocrine, Inc. - Aerocrine NO monitor cleared by U.S. FDA for monitoring asthma therapy
Alnylam Pharmaceuticals, Inc. - GeneCare Research Institute granted licenses to IP for RNAi therapeutics
American College of Sports Medicine, Philadelpia - Drug prophylaxis recommended even for physically active postmenopausal women
Artes Medical Inc. - Request granted for re-examination of competitor's injectable skin filler patent
AstraZeneca - Council recommends approval of Crestor in Japan
AtheroGenics, Inc. - Pharmaceutical firm announces proposed offering of notes
Avanir Pharmaceuticals - Orally active asthma/allergy drug candidate subject of journal article
Avant Immunotherapeutics - $2M milestone payment issued for marketing approval of Rotarix
Ben Gurion University Negev, Beer Sheva - Ciliary protein phosphorylation regulated by Ca2+ and nitric oxide
BioAlliance Pharma - Preliminary phase III data reported on miconazole Lauriad
BioDelivery Sciences International, Inc. - Bioral drug delivery may reduce GI damage caused by NSAIDs, aspirin
BioXell, Milan - Antigen-based immuno-intervention in human autoimmune diseases reviewed
Biosite Incorporated - PMA application filed for Triage Stroke Panel
Biotechnology Industry Organization - Former governor James Greenwood assumes presidency of biotechnology association
Brigham & Women's Hospital, Boston - LIR3 counter-regulatory for both adaptive and innate receptors
Brown University - Serotonin receptor antagonists may be useful in the treatment of PML
Brown University, Providence - High-affinity antibody steers therapy to hepatocellular carcinoma
CHU Laval, Quebec City - Phi C31 integrase and nucleofection create stable transgene expression
CSIRO - Link between insulin receptor and epidermal growth factor receptors reviewed
California Walnuts - Walnut foundation comments on new U.S. Dietary Guidelines
Cancer Care Consultants - Cancer center installs optical tracking technology for radiation treatment
CardioGenesis Corporation - FDA approves laser for transmyocardial revascularization
Cel-Sci Corp. - Phase III trial application filed for Multikine
Centocor, Inc. - Effect of site-specific pegylation on abciximab efficacy determined
Central Drug Research Institute, Lucknow - Thiazolidinedione derivatives with antihyperglycemic activity synthesized
Chang Gung University - SPARC gene shows promise as prognostic marker
ChemoCentryx, Inc. - Phase II clinical trial of Traficet-EN in IBD begins
Chemokine Therapeutics Corp. - Biotech company completes IPO, raises CDN$16M
Chronogen, Inc. - Sosei inks agreement for screening of its Drug Reprofiling Platform library
City University of New York - Global alliance for vaccines not a model for public-private cooperation
Cleveland Clinic Foundation - Recent findings illuminate research in immunology
Corautus Genetics, Inc. - Results of gene-transfer approach to vascular disease using stents published
Corgentech, Inc. - IND filed for phase I/II trial of new drug candidate for eczema
Cornell University, Ithaca - Caco2 cell model used to study bioavailability of whole food phytochemicals
Cyprus Institute of Neurology & Genetics - Star polymers ferry plasmids to cancer cells
DNAX Research Institute, Palo Alto - IL-12 and IL-23 work together to protect host and prevent tumor development
Dana-Farber Cancer Institute - Maytansinoid immunoconjugate B-B4-DM1 kills multiple myeloma cells
Diet & Nutrition - Federal grant funds healthy-choices study in Mount Vernon
Diet & Nutrition - New government guidelines emphasize calories, exercise
Disease Outbreak - United Nations confirms two cases of measles in tsunami-hit Sumatra
Dr. Foster - New figures highlight trends in drug and alcohol misuse
Duke University - Iron deficiency sparks dramatic changes in gene expression
Ege University Hospital - Researchers report details of new studies and findings in the area of oncology
Gemin X Biotechnologies, Inc. - Gemin X Biotechnologies initiates phase I/II clinical trial with GX15-070 in CLL
Genentech, Inc. - Company finalizes Avastin label with previously announced safety information
GlaxoSmithKline - Company announces expanded indication for BEXXAR in NHL
MGI PHARMA, Inc. - Dacogen NDA accepted for filing by U.S. FDA
Noven Pharmaceuticals, Inc. - Drug delivery company submits comments to FDA regarding generic Duragesic
RedPrairie Corporation - Supply chain company supports U.S. FDA food & beverage bioterrorism regulations
RetinaPharma Technologies, Inc - U.S. FDA clearance received for TonoPach enabling easier diagnosis of glaucoma
Selective Micro Technologies - Technology company gets U.S. FDA approval for biocide chlorine dioxide
U.S. Food & Drug Administration - Multiclass methods developed for drug residues in eggs
U.S. National Institutes of Health - Chimpanzee Fab fragments and IgG cross-neutralize dengue viruses
U.S. National Institutes of Health - West Nile Virus-like particles induced sterilizing immunity
Valeant Pharmaceuticals - Company submits response to U.S. FDA approvable letter, appoints new CEO
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.